StreetAlpha.app
Home › Stocks › VRAX

Virax Biolabs Group Ltd (VRAX)

$0.33
▼ −12.89%
LAST CLOSE · NOV 20

Virax Biolabs makes diagnostic substances used in medical testing, based in Lanarkshire, United Kingdom. It last closed at $0.33 on Nov 20, down 12.89% on the day.

AI Auto Pilots
Is VRAX in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold VRAX.

Key Stats

Fiscal 2025
Results
Revenue
$6K
−96.0% vs a year ago
Net income
−$6.1M
−95739.2% margin
Free cash flow
−$5.2M
−81621.6% margin
Gross margin
−838.2%
−$53K gross profit
Balance sheet
Cash & equivalents
$4.2M
At Mar 31
Shareholder equity
$5.5M
Fiscal year endsMarch
ExchangeNasdaq
Financials history
FY2021: $124K$124KFY2021FY2022: $0$0FY2022FY2023: $9K$9KFY2023FY2024: $156K$156KFY2024FY2025: $6K$6KFY2025

From VRAX's SEC filings, latest 20-F for the period ending Mar 31, 2025 (filed Jul 6). Per share figures are left out because the US listing can represent a different number of shares.

Next report
—
No date on the calendar yet
Consensus EPS forecast
EPS and revenue estimates
Year-ago EPS
Same quarter last year
Options-implied move
Move priced in by options
Analyst consensus
Ratings from the last 90 days
Loading…

Technical Analysis

VRAX · as of the Nov 20 close · updated each morning
Downtrend, oversold

The stock is 152% below its 20 day and 371% below its 50 day average. It is 938% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 17), oversold. The nearest support is the Pivot S1 at $0.32, and the nearest resistance the Pivot at $0.34.

Short trendBearish
Long trendBearish
MomentumWeak
StretchOversold
VolatilityHigh, 53.4%/day
Key levels
$21.7552 week high+6490.9%
$3.45200 day average+945.5%
$2.35100 day average+612.1%
$1.5650 day average+372.7%
$1.33Swing high (Oct 29)+303.0%
$0.8420 day average+154.5%
$0.36Pivot R1+9.1%
$0.34Pivot+3.0%
$0.33Last close
$0.32Pivot S1−3.0%
$0.2952 week low−12.1%
Indicators
RSI (14)17.31Oversold below 30Oversold
MACD-0.35Below its signal lineBearish
Stochastic4.2Near the bottom of its rangeOversold
ADX (14)25.0Trending down
Williams %R-96.9Oversold below −80, overbought above −20Oversold
CCI (20)-105.2Oversold below −100, overbought above 100Oversold
Rate of change−58.1%Change over 10 sessionsBearish
ATR (14)$0.18Typical daily range, 53.4% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for VRAX

What happened before

See how VRAX did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

November seasonalityHow VRAX usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Seasonality

How VRAX has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2022.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Whale options flow for VRAXHow many large options trades hit VRAX, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

VRAX Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Bullish
Strongly bearishNeutralStrongly bullish
  • ▲4 buying vs 0 selling
  • ▲Shares held by funds +25.7%
  • ▲Funds holding +2
  • ●No superinvestor moves
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holding
Q3 2026This quarterLast quarterChange
Funds holding42+100.0%
In funds' top 1000–
Held by funds–––
New / increased2 / 22 / 0+100.0%
Reduced / sold out0 / 00 / 4−100.0%
Put/call ratio–––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See VRAX institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether VRAX is in one of them and how their past VRAX trades turned out.

VRAX in the AI portfolios
Loading…

VRAX News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered VRAX in an article yet. Here's the latest on the wider market.

VRAX in the news

About Virax Biolabs Group

Virax Biolabs Group makes diagnostic substances, the materials used in medical tests carried out both outside the body and inside it. The company is based in Lanarkshire, in the United Kingdom, and operates in the medical diagnostics field. Its work centers on medical testing, and its customers are organizations that carry out diagnostic testing.

Headquarters
Lanarkshire, United Kingdom